The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
Novel Treatment Using Low-Dose Naltrexone for Lichen Planopilaris
J Drugs Dermatol
01 November 2017
https://pubmed.ncbi.nlm.nih.gov/29141063/
Utility of Naltrexone Treatment for Chronic Inflammatory Dermatologic Conditions: A Systematic Review
JAMA Dermatol
01 February 2019
https://pubmed.ncbi.nlm.nih.gov/30484835/
The uses of naltrexone in dermatologic conditions
J Am Acad Dermatol
June 2019
https://pubmed.ncbi.nlm.nih.gov/30582992/
Background: Naltrexone in standard and reduced doses is efficacious in many inflammatory and acantholytic disorders.
Objective: We summarized the current data of naltrexone that are relevant to dermatologic practice.
Inexpensive Compounding of Low-Dose Naltrexone With Orange Juice
J Am Acad Dermatol
28 March 2019
https://www.practiceupdate.com/content/inexpensive-compounding-of-low-d…
Inexpensive method to formulate low-dose naltrexone (LDN) at any local pharmacy by compounding full-dose naltrexone tablets into orange juice. This formulation can be dispensed with a dropper or mixed into a larger volume of juice.
The Use of Naltrexone in Dermatology. Current Evidence and Future Directions
Curr Drug Targets
2019
https://pubmed.ncbi.nlm.nih.gov/30887922/
The efficacy and safety of oral low dose naltrexone versus placebo in the patients with lichen planopilaris; a randomized controlled clinical trial
J Dermatolog Treat
08 June 2020
https://pubmed.ncbi.nlm.nih.gov/32449418/
Laurie Marzell, ND - LDN Case Studies (2017 Conference) (LDN, low dose naltrexone)